PRKCD and breast cancer: This result suggests that PKCδ expression is necessary for GIC tumor growth in vivo, and is consistent with the reported inhibitory effects of PKCδ shRNA on the growth of xenografts of prostate, pancreas, and breast cancer stem cells (Chen et al, 2014).